| Literature DB >> 34277670 |
Yuxin Tong1,2, Tiantian Wang3, Xinyu Zhang1,2, Yi He4, Bing Jiang1,2.
Abstract
Background: This study aimed to assess the differences in the average and sectoral peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell plus inner plexiform layer (mGCIPL), and macular ganglion cell complex (mGCC) thickness using optical coherence tomography (OCT) in patients with pre-perimetric glaucoma (PPG) compared to those with early perimetric glaucoma (EG) and ocular hypertension (OHT).Entities:
Keywords: early perimetric glaucoma; ganglion cell complex; ganglion cell plus inner plexiform layer; ocular hypertension; optical coherence tomography; pre-perimetric glaucoma; retinal nerve fiber layer
Year: 2021 PMID: 34277670 PMCID: PMC8280320 DOI: 10.3389/fmed.2021.696004
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1Flow diagram of included studies.
Characteristics of included studies.
| Wang et al. ( | 2020 | China | 26 | 22 | 36.9 ± 11.1 | 41.4 ± 13.9 | 6/16 | 7/12 | RTVue | POAG | pRNFL, GCC | 6 × 6 | ||||
| Sarigül Sezenöz et al. ( | 2020 | Turkey | 28 | 31 | 18 | 66.71 ± 11.33 | 68.20 ± 9.12 | 66.61 ± 10.44 | N/A | N/A | N/A | Heidelberg | Mixed | pRNFL, GCC, total retina thickness, G/T ratio | ||
| Lu et al. ( | 2020 | China | 44 | 42 | 43 ± 11 | 46 ± 11 | 17/27 | 20/22 | RTVue | POAG | pRNFL, GCC | 4.5 × 4.5 | 6 × 6 | |||
| Hou et al. ( | 2019 | USA | 68 | 162 | 68.4 ± 10.8 | 68.4 ± 8.6 | 30/25 | 60/61 | RTVue Spectralis | POAG | pRNFL, GCC | 3 × 3 | ||||
| Kim et al. ( | 2017 | Korea | 26 | 26 | 52.08 ± 11.77 | 55.65 ± 13.36 | 16/10 | 16/10 | CirrusSpectralis | OAG | mRNFL, GCIPL, GCL, IPL | 6 × 6 | ||||
| Aydogan et al. ( | 2017 | Turkey | 94 | 66 | 77 | 53.2 ± 11.1 | 59.4 ± 9.5 | 52.8 ± 8.2 | 57/37 | 36/30 | 62/15 | RTVue | Mixed | pRNFL, GCC, TR, OR | 3.45-mm circle | 7 × 7 |
| Akil et al. ( | 2017 | USA | 20 | 20 | 63.13 ± 16.43 | 65.375 ± 5.2 | 10/10 | 8/12 | Cirrus | POAG | pRNFL | 3.4-mm circle | ||||
| Kumar et al. ( | 2016 | India | 28 | 83 | 57.04 ± 2.78 | 61.2 ± 1.34 | N/A | N/A | RTVue | Mixed | pRNFL, GCC | 3.45-mm circle | 6 × 6 | |||
| Cennamo et al. ( | 2016 | Italy | 66 | 41 | 64.86 ± 7.12 | 63.78 ± 11.70 | 30/36 | 25/16 | RTVue | OAG | pRNFL, GCC | 3.45-mm circle | 7 × 7 | |||
| Park et al. ( | 2015 | Korea | 50 | 106 | 58.2 ± 13.7 | 56.0 ± 12.7 | 26/24 | 66/40 | Cirrus | Mixed | pRNFL, GCIPL, TNM ratio | 3.46-mm circle | 6 × 6 × 2 | |||
| Kim et al. ( | 2015 | Korea | 79 | 83 | 54.6 ± 11.8 | 57.5 ± 11.6 | 40/39 | 43/40 | Cirrus | Mixed | pRNFL, GCIPL | Optic disc Cube 200 × 200 | Macular Cube 512 × 128 | |||
| Hwang et al. ( | 2015 | Korea | 48 | 110 | 51.7 ± 13.8 | 51.6 ± 12.7 | N/A | N/A | Cirrus | Mixed | GCIPL | 6 × 6 | ||||
| Yamada et al. ( | 2014 | Japan | 30 | 31 | 56.9 ± 14.7 | 61.8 ± 11.5 | 13/17 | 19/12 | Spectralis | Mixed | mRNFL, GCC, GCL, TR | 30 × 15 degreed macular area | ||||
| Sung et al. ( | 2014 | Korea | 37 | 70 | 54.22 ± 12.70 | 53.97 ± 12.36 | 20/17 | 29/41 | Cirrus | Mixed | pRNFL, GCIPL | 3.46-mm circle | 14.13 mm2 elliptical annulus area | |||
| Kim et al. ( | 2014 | Korea | 68 | 72 | 53.12 ± 10.69 | 56.83 ± 12.73 | N/A | N/A | 3D OCT-2000 | OAG | pRNFL, mRNFL, GCIPL, GCC | 3.46-mm circle | 6 × 6 | |||
| Kim et al. ( | 2014 | Korea | 103 | 111 | 57.2 ± 11.8. | 56.8 ± 11.4 | 52/51 | 52/59 | Cirrus | OAG | pRNFL, GCIPL | 3.46-mm circle | Macular Cube 200 × 200 | |||
| Holló et al. ( | 2014 | Hungary | 33 | 28 | 56.2 ± 12.1 | 50.7 ± 15.6 | N/A | N/A | RTVue | Mixed | pRNFL, GCC, total retina thickness, G/T ratio | 4-mm circle | ||||
| Arintawati et al. ( | 2013 | Japan | 32 | 81 | 58.94 ± 12.15 | 60.16 ± 16.77 | 18/14 | 45/36 | RTVue | Mixed | pRNFL, GCC, FLV, GLV | 3.5-mm circle | 7 × 7 | |||
| Pomorska et al. ( | 2012 | Poland | 33 | 27 | 61.0 ± 9.6 | 57.8 ± 11.2 | 17/16 | 18/9 | Sratus | Mixed | pRNFL | 3.4-mm circle | ||||
| Morooka et al. ( | 2012 | Japan | 23 | 24 | 56.8 ± 9.4 | 51.9 ± 12.2 | 16/7 | 13/11 | RS3000 | Mixed | pRNFL, GCC | 3.45-mm circle | 9 × 9 | |||
| Horn et al. ( | 2011 | Germany | 77 | 52 | 59.2 ± 10.0 | 60.8 ± 10.5 | 41/36 | 27/25 | Sepctralis | OAG | pRNFL | 3.4-mm circle | ||||
| Garas et al. ( | 2011 | Hungary | 46 | 36 | 57.6 ± 11.8 | 51.5 ± 16.5 | N/A | N/A | RTVue | Mixed | pRNFL, GCC, FLV | 4-mm circle | ||||
| Taliantzis et al. ( | 2009 | Greece | 42 | 54 | 58.1 ± 11.6 | 56.7 ± 13.2 | 20/22 | 25/29 | Stratus | Mixed | pRNFL | 3.4-mm circle | ||||
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; OHT, ocular hypertension; OAG, open-angle glaucoma; POAG, primary open-angle glaucoma; Mixed, unclassified glaucoma or more than one types of glaucoma; pRNFL, peripapillary retinal nerve fiber layer; mRNFL, macular retinal nerve fiber layer; GCIPL, ganglion cell plus inner plexiform layer; GCL, ganglion cell layer; IPL, inner plexiform layer; GCC, ganglion cell complex; G/T ratio, macular GCC to total retinal thickness; TR, macular total retinal parameters; OR, macular outer retinal parameters; FLV, focal loss volume; GLV, global loss volume; TNM ratio, temporal to nasal macular GCIPL thickness ratio; F/M, female/male; ONH, optic nerve head.
Methodological quality of included studies.
| Wang et al. ( | 6 | M | |||||||||||
| Sarigül Sezenöz et al. ( | 5 | M | |||||||||||
| Lu et al. ( | 6 | M | |||||||||||
| Hou et al. ( | 6 | M | |||||||||||
| Kim et al. ( | 6 | M | |||||||||||
| Aydogan et al. ( | 6 | M | |||||||||||
| Akil et al. ( | 7 | M | |||||||||||
| Kumar et al. ( | 7 | M | |||||||||||
| Cennamo et al. ( | 6 | M | |||||||||||
| Park et al. ( | 8 | H | |||||||||||
| Kim et al. ( | 7 | M | |||||||||||
| Hwang et al. ( | 5 | M | |||||||||||
| Yamada et al. ( | 8 | H | |||||||||||
| Sung et al. ( | 7 | M | |||||||||||
| Kim et al. ( | 8 | H | |||||||||||
| Kim et al. ( | 6 | M | |||||||||||
| Holló et al. ( | 6 | M | |||||||||||
| Arintawati et al. ( | 5 | M | |||||||||||
| Pomorska et al. ( | 6 | M | |||||||||||
| Morooka et al. ( | 7 | M | |||||||||||
| Horn et al. ( | 6 | M | |||||||||||
| Garas et al. ( | 7 | M | |||||||||||
| Taliantzis et al. ( | 5 | M | |||||||||||
AHRQ, Agency for Healthcare Research and Quality; H, high quality; M, moderate quality; L, low quality; high quality (score: 8–11); moderate quality (score: 4–7); low quality (score: 0–3). i, Define the source of information; ii, List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications; iii, Indicate time period used for identifying patients; iv, Indicate whether or not subjects were consecutive if not population-based; v, Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants; vi, Describe any assessments undertaken for quality assurance purposes; vii, Explain any patient exclusions from analysis; viii, Describe how confounding was assessed and/or controlled; ix, If applicable, explain how missing data were handled in the analysis; x, Summarize patient response rates and completeness of data collection; xi, Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained. .
Figure 2pRNFL thickness in patients with PPG and EG. (A) Average. (B) Superior. (C) Nasal. (D) Inferior. (E) Temporal.
Figure 3mGCIPL thickness in patients with PPG and EG. (A) Average. (B) Superior. (C) Inferior.
Figure 4mGCC thickness in patients with PPG and EG. (A) Average. (B) Superior. (C) Inferior.
Subgroup analysis of average and sectoral pRNFL, mGCIPL and mGCC thickness according to the type of glaucoma in patients with PPG and EG.
| Average | 4 | 0% | 0.42 | 7.45 (5.30, 9.59) | 6.81 | <0.00001 |
| Superior | 3 | 0% | 0.70 | 11.75 (6.47, 17.04) | 4.36 | <0.0001 |
| Inferior | 3 | 0% | 0.64 | 13.07 (8.24, 17.89) | 5.31 | <0.00001 |
| Average | 4 | 0% | 0.41 | 8.99 (7.02, 10.96) | 8.94 | <0.00001 |
| Superior | 2 | 76% | 0.04 | 8.19 (−0.95, 17.33) | 1.76 | |
| Inferior | 2 | 88% | 0.003 | 12.34 (0.03, 24.65) | 1.97 | 0.05 |
| Average | 8 | 84% | <0.00001 | 7.60 (4.13, 11.07) | 4.29 | <0.0001 |
| Superior | 6 | 75% | 0.001 | 9.41 (5.29, 13.53) | 4.48 | <0.00001 |
| Inferior | 6 | 83% | <0.0001 | 12.47 (6.41, 18.52) | 4.03 | <0.0001 |
| Average | 3 | 75% | 0.02 | 5.44 (2.57, 8.31) | 3.72 | 0.0002 |
| Superior | 2 | 0% | 0.84 | 2.96 (1.46, 4.46) | 3.87 | 0.0001 |
| Inferior | 2 | 0% | 0.61 | 5.00 (3.52, 6.47) | 6.65 | <0.00001 |
| Average | 4 | 55% | 0.08 | 4.63 (2.87, 6.40) | 5.14 | <0.00001 |
| Superior | 4 | 84% | 0.0003 | 4.16 (0.87, 7.45) | 2.48 | 0.01 |
| Inferior | 4 | 46% | 0.13 | 7.32 (5.84, 8.80) | 9.66 | <0.00001 |
| Average | 3 | 58% | 0.09 | 7.38 (4.09, 10.67) | 4.40 | <0.0001 |
| Superior | 2 | 68% | 0.08 | 5.81 (0.29, 11.33) | 2.06 | 0.04 |
| Inferior | 2 | 74% | 0.05 | 10.05 (3.51, 16.59) | 3.01 | 0.003 |
| Average | 2 | 86% | 0.007 | 5.86 (−0.98, 12.70) | 1.68 | |
| Superior | 2 | 0% | 0.39 | 3.79 (1.27, 6.32) | 2.95 | 0.003 |
| Inferior | 2 | 92% | 0.0004 | 7.85 (−3.17, 18.86) | 1.40 | |
| Average | 5 | 89% | <0.00001 | 7.37 (2.64, 12.11) | 3.05 | 0.002 |
| Superior | 3 | 78% | 0.01 | 3.96 (0.12, 7.80) | 2.02 | 0.04 |
| Inferior | 3 | 78% | 0.01 | 5.23 (1.14, 9.32) | 2.51 | 0.01 |
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; POAG, primary open-angle glaucoma; OAG, open-angle glaucoma; Mixed, unclassified glaucoma or more than one types of glaucoma; pRNFL, peripapillary retinal nerve fiber layer; mGCIPL, macular ganglion cell plus inner plexiform layer; mGCC, macular ganglion cell complex; WMD, weighted mean difference; CI, confidence interval; I.
Subgroup analysis of average and sectoral pRNFL thickness according to the type of OCT in patients with PPG and EG.
| Average | 6 | 81% | <0.0001 | 6.96 (2.96, 10.95) | 3.42 | 0.0006 |
| Superior | 6 | 71% | 0.004 | 7.51 (2.98, 12.04) | 3.25 | 0.001 |
| Nasal | 2 | 0% | 1.00 | 8.70 (6.72, 10.68) | 8.60 | <0.00001 |
| Inferior | 6 | 77% | 0.0006 | 9.18 (4.13, 14.22) | 3.56 | 0.0004 |
| Temporal | 2 | 0% | 0.64 | 7.56 (4.64, 10.49) | 5.06 | <0.00001 |
| Average | 5 | 56% | 0.06 | 9.67 (7.09, 12.25) | 7.35 | <0.00001 |
| Superior | 4 | 14% | 0.32 | 12.04 (8.91, 15.17) | 7.53 | <0.00001 |
| Nasal | 3 | 93% | 0.00001 | 6.38 (-1.02, 13.78) | 1.69 | |
| Inferior | 4 | 0% | 0.56 | 16.18 (13.24, 19.13) | 10.77 | <0.00001 |
| Temporal | 4 | 89% | <0.00001 | 7.74 (2.20, 13.29) | 2.74 | 0.006 |
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; pRNFL, peripapillary retinal nerve fiber layer; OCT, optical coherence tomography; SD-OCT, spectral domain OCT; WMD, weighted mean difference; CI, confidence interval; I.
Subgroup analysis of average and sectoral mGCC thickness according to the macular scan area (mm2) in patients with PPG and EG.
| Average | 4 | 25% | 0.26 | 8.09 (5.91, 10.27) | 7.27 | <0.00001 |
| Superior | 3 | 18% | 0.29 | 5.28 (2.69, 7.86) | 4.00 | <0.0001 |
| Inferior | 3 | 61% | 0.08 | 11.44 (7.38, 15.50) | 5.53 | <0.00001 |
| Average | 3 | 95% | <0.00001 | 5.36 (−3.27, 13.99) | 1.22 | |
| Superior | 3 | 80% | 0.006 | 3.54 (−0.64, 7.72) | 1.66 | |
| Inferior | 3 | 76% | 0.01 | 3.35 (−1.08, 7.79) | 1.48 | |
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; mGCC, macular ganglion cell complex; WMD, weighted mean difference; CI, confidence interval; I.
Figure 5pRNFL thickness in patients with PPG and OHT. (A) Average. (B) Superior. (C) Inferior.
Figure 6mGCC thickness in patients with PPG and OHT. (A) Average. (B) Superior. (C) Inferior.
Begg's and Egger's tests results for the evaluation of publication bias.
| Average | 16 | 0.23 | 0.822 | −0.55 | 0.589 |
| Superior | 11 | 0.62 | 0.533 | −0.53 | 0.606 |
| Nasal | 6 | 0.00 | 1.000 | −1.21 | 0.292 |
| Inferior | 11 | 1.71 | 0.087 | −0.76 | 0.465 |
| Temporal | 7 | 0.30 | 0.764 | −0.60 | 0.573 |
| Average | 10 | 1.07 | 0.283 | 0.20 | 0.849 |
| Superior | 7 | 0.00 | 1.000 | 0.04 | 0.973 |
| Inferior | 7 | 0.00 | 1.000 | −0.11 | 0.920 |
| Average | 7 | 1.20 | 0.230 | 1.50 | 0.195 |
| Superior | 6 | 0.38 | 0.707 | 0.26 | 0.806 |
| Inferior | 6 | 0.00 | 1.000 | 0.36 | 0.735 |
| Average | 6 | 1.13 | 0.260 | 2.71 | 0.053 |
| Superior | 4 | −0.34 | 1.000 | 0.85 | 0.487 |
| Inferior | 4 | 0.34 | 0.734 | 3.32 | 0.08 |
| Average | 4 | 0.34 | 0.734 | −1.84 | 0.206 |
| Superior | 3 | 0.00 | 1.000 | 0.51 | 0.700 |
| Inferior | 3 | 0.00 | 1.000 | 1.10 | 0.471 |
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; OHT, ocular hypertension; pRNFL, peripapillary retinal nerve fiber layer; mGCC, macular ganglion cell complex; mGCIPL, macular ganglion cell plus inner plexiform layer.
Sensitivity analysis of average mGCIPL thickness in patients with PPG and EG.
| Park et al. ( | 4.71 (3.80, 5.63) | <0.00001 | 5.00 (3.35, 6.65) | <0.00001 | 66% |
| Kim et al. ( | 4.26 (3.30, 5.23) | <0.00001 | 4.60 (3.02, 6.18) | <0.00001 | 59% |
| Hwang et al. ( | 4.97 (4.05, 5.88) | <0.00001 | 5.21 (3.80, 6.62) | <0.00001 | 54% |
| Sung et al. ( | 4.50 (3.60, 5.40) | <0.00001 | 4.68 (3.12, 6.24) | <0.00001 | 64% |
| Kim et al. ( | 4.75 (3.80, 5.70) | <0.00001 | 5.03 (3.32, 6.73) | <0.00001 | 66% |
| Kim et al. ( | 4.87 (3.90, 5.85) | <0.00001 | 5.10 (3.41, 6.78) | <0.00001 | 64% |
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; mGCIPL, macular ganglion cell plus inner plexiform layer; WMD, weighted mean difference; CI, confidence interval; I.
Sensitivity analysis of average mGCC thickness in patients with PPG and EG.
| Wang et al. ( | 7.51 (6.46, 8.56) | <0.00001 | 6.78 (3.98, 9.58) | <0.00001 | 85% |
| Sarigül Sezenöz et al. ( | 7.56 (6.52, 8.61) | <0.00001 | 6.85 (4.06, 9.65) | <0.00001 | 85% |
| Lu et al. ( | 7.69 (6.61, 8.76) | <0.00001 | 7.17 (4.23, 10.11) | <0.00001 | 85% |
| Hou et al. ( | 8.27 (7.11, 9.43) | <0.00001 | 7.44 (4.43, 10.45) | <0.00001 | 84% |
| Kumar et al. ( | 7.86 (6.77, 8.95) | <0.00001 | 7.33 (4.36, 10.31) | <0.00001 | 85% |
| Cennamo et al. ( | 8.09 (7.02, 9.16) | <0.00001 | 7.73 (5.00, 10.45) | <0.00001 | 83% |
| Yamada et al. ( | 7.78 (6.70, 8.85) | <0.00001 | 7.29 (4.35, 10.23) | <0.00001 | 85% |
| Kim et al. ( | 7.49 (6.40, 8.57) | <0.00001 | 6.95 (3.98, 9.91) | <0.00001 | 85% |
| Arintawati et al. ( | 8.17 (7.10, 9.24) | <0.00001 | 7.90 (5.34, 10.46) | <0.00001 | 80% |
PPG, pre-perimetric glaucoma; EG, early perimetric glaucoma; mGCC, macular ganglion cell complex; WMD, weighted mean difference; CI, confidence interval; I.
Sensitivity analysis of average mGCC thickness in patients with PPG and OHT.
| Sarigül Sezenöz et al. ( | −2.16 (−3.53,−0.79) | 0.002 | −3.28 (−6.75, 0.19) | 0.06 | 80% |
| Holo et al. ( | −1.49 (−2.92, −0.06) | 0.04 | −1.93 (−4.05, 0.19) | 0.08 | 39% |
| Garas et al. ( | −1.96 (−3.42, −0.51) | 0.008 | −3.52 (−7.20, 0.69) | 0.11 | 79% |
PPG, pre-perimetric glaucoma; OHT, ocular hypertension; mGCC, macular ganglion cell complex; WMD, weighted mean difference; CI, confidence interval; I.